Historical Overview of Obesity Pharmacotherapy Pharmacologic treatment for obesity began in 1893 with thyroid hormone extracts, introduced due to their capacity to increase metabolic rate and reduce weight gain.(4) However, they were soon abandoned due to cardiovascular side effects and lack of sustainable results.(4) In 1959, phentermine was approved by the U.S
By providing an abundant supply of Acetyl-CoA, ALCAR effectively supercharges the brain's ability to produce acetylcholine, directly counteracting the neurotransmitter depletion caused by neuroinflammation
Although its best practice to involve nutritionists in GLP-1 therapy, medical professionals often lack a clear resource to turn to
Funding This study was partially supported by the Fundao Carlos Chagas Filho de Amparo Pesquisa do Estado do Rio de Janeiro (FAPERJ - E-26/201.289/2022
Increased total cholesterol, triglycerides, and lipoproteins like low and very-low-density lipoprotein have a negative impact on insulin sensitivity
Wear socks and a warm hat